Catalent Cell & Gene Therapy
Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) vectors and CAR-T immunotherapies, with deep experience in viral vector scale-up and production. Catalent recently acquired MaSTherCell, adding expertise in autologous and allogeneic cell therapy development and manufacturing to position Catalent as a premier technology, development, and manufacturing partner for innovators across the entire field of advanced biotherapeutics.
Products & Services
Documents & Links
LumaCyte Tech NoteRadiance® Label-Free Monitoring of AAV Transfection in HEK293 Cells Using Laser Force Cytology™